2',3'-dideoxycytidine permeation of the human erythrocyte membrane.
The mechanism by which 2,3'-dideoxycytidine, an inhibitor of HIV-I infectivity, permeates the cell membrane was investigated. The influx of ddCyd into human erythrocytes was nonconcentrative. The initial velocity of both ddCyd influx and efflux was, in contrast to compounds that permeate the cell membrane via the nucleoside transporter, a linear function of nucleoside concentration in the 1 microM to 10 mM range and relatively insensitive to temperature. Furthermore, potent inhibitors of nucleoside transporter and other nucleosides were found to inhibit ddCyd influx only partially or not at all suggesting that ddCyd permeates the human erythrocyte membrane predominantly by nonfacilitated diffusion. This unusual characteristic seems to be due to the lack of 3'-hydroxyl moiety of ddCyd which appears to be an important determinant for the nucleoside carrier specificity rather than to lipid solubility itself. As far as permeation of the cell membrane is concerned ddCyd shares these properties with 2',3'-dideoxythymidine and 3'-azido-3'-deoxythymidine.
Magnani
M
M
Istituto di Chimica Biologica, Università degli Studi, Urbino, Italy.
Bianchi
M
M
Rossi
L
L
Stocchi
V
V
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D001692:Biological Transport / Q000187:drug effects; D004058:Diffusion; D004176:Dipyridamole / Q000494:pharmacology; D004910:Erythrocyte Membrane / Q000378:metabolism*; D006358:Hot Temperature; D006801:Humans; D066298:In Vitro Techniques; D013868:Thioinosine / Q000494:pharmacology / Q000031:analogs & derivatives; D016047:Zalcitabine / Q000097:blood / Q000493:pharmacokinetics*
D013868:Thioinosine; D004176:Dipyridamole; D016047:Zalcitabine; C001789:4-nitrobenzylthioinosine